Status:

WITHDRAWN

Effects of a Red/Gold/IR LED Combination Light on Reduction of Fat

Lead Sponsor:

Ward Photonics LLC

Conditions:

Body Image

Diabetes Mellitus, Type 2

Eligibility:

All Genders

18+ years

Brief Summary

An open-label evaluation of the effects of a red/gold/IR LED combination light on reduction of fat. The results shall be compared to previous results from a comparator device utilizing only red LED mo...

Detailed Description

The combination of gold/red/IR light is theorized to enhance the effect of the deeper penetrating red/IR light with the photomodulated effects of gold light. The light is positioned alongside the pati...

Eligibility Criteria

Inclusion

  • Study participant is 18 years of age or older.
  • Diagnosed with adult-onset (type 2) diabetes.
  • Obesity

Exclusion

  • Photosensitive condition or medication.
  • Active chemotherapy treatment or other cancer treatment.
  • Pregnant, possibly pregnant or planning pregnancy prior to the end of study participation.
  • Developmental disability or cognitive impairment that, in the opinion of the investigator, would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements.
  • Chronic stomach conditions (IBS, Crohn's, Ulcerative Colitis, etc.)

Key Trial Info

Start Date :

August 7 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 31 2021

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04525573

Start Date

August 7 2020

End Date

December 31 2021

Last Update

July 18 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Horizon Medical Center

Schaumburg, Illinois, United States, 60173